US · Healthcare

Aligos Therapeutics Inc (ALGS)

Biotechnology

Aligos Therapeutics Inc (ALGS) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ALGS

P/E ratio

25.00

Aligos Therapeutics Inc (ALGS) — FAQ

What is ALGS's P/E ratio?

The price-to-earnings (P/E) ratio for Aligos Therapeutics Inc (ALGS) is 25.00 (data as of 2026-05-23).

Does Aligos Therapeutics Inc pay a dividend?

Dividend yield is not available in the current snapshot for Aligos Therapeutics Inc (ALGS). Check the MyAverix Finance app for the latest dividend data.

What sector is Aligos Therapeutics Inc in?

Aligos Therapeutics Inc (ALGS) is classified in the Healthcare sector (Biotechnology industry).

What exchange is ALGS listed on?

ALGS is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)